Catherine Isted, a financial expert, is to become chief executive of ReNeuron Group Plc to drive the company’s exosome drug delivery technology forward. She is currently chief financial officer and will move into the CEO position on 1 September. Ms Isted was previously head of corporate development and investor relations at Oxford Biomedica Plc. She has also been partner at Peel Hunt, a UK investment bank. She holds a bachelor’s degree in chemistry from the University of Leicester and is certified by the Chartered Institute of Management Accountants of the UK.
ReNeuron announced the appointment on 1 August 2022.
Copyright 2022 Evernow Publishing Ltd